Hélène Rey

Title: Hélène Rey: Innovator in Pharmaceutical Treatments

Introduction

Hélène Rey is a notable inventor based in Kembs, France. She has made significant contributions to the field of pharmaceuticals, particularly in the treatment of opioid-induced constipation. With a total of 4 patents to her name, her work is characterized by innovative methods and compositions that enhance patient care.

Latest Patents

One of her latest patents is a method and composition for the treatment of opioid-induced constipation. This invention involves a solid oral pharmaceutical dosage form that includes an opioid receptor antagonist. The formulation is designed to provide effective treatment with a specific dosage of naloxone hydrochloride, ensuring a rapid first-pass metabolism and a consistent level of the drug in the bloodstream. Another significant patent is for naloxone single agent and multilayer tablets. This composition is engineered to release the active substance in a prolonged manner, suitable for administration over an extended period, thus improving the management of opioid-induced constipation.

Career Highlights

Hélène Rey has worked with several companies throughout her career, including Develco Pharma Schweiz AG and Algobate AG. Her experience in these organizations has allowed her to develop and refine her innovative pharmaceutical solutions.

Collaborations

Some of her notable coworkers include Olaf Mundszinger and Isabelle Golfier. Their collaboration has contributed to the advancement of her research and the successful development of her patents.

Conclusion

Hélène Rey's contributions to pharmaceutical innovations, particularly in the treatment of opioid-induced constipation, highlight her role as a leading inventor in the field. Her patents reflect a commitment to improving patient outcomes through effective medication delivery systems.